anmelden
NYSE International 100
11.186,73
PKT
-82,12
PKT
-0,73
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu NYSE International 100-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 03.02.22 | ABB (Asea Brown Boveri) Hold | Jefferies & Company Inc. | |
| 03.02.22 | Vodafone Group Outperform | Credit Suisse Group | |
| 03.02.22 | Santander Neutral | Credit Suisse Group | |
| 03.02.22 | Unilever Outperform | Credit Suisse Group | |
| 03.02.22 | Shell (ex Royal Dutch Shell) Overweight | JP Morgan Chase & Co. | |
| 03.02.22 | Novartis Neutral | Credit Suisse Group | |
| 03.02.22 | BBVA Buy | Jefferies & Company Inc. | |
| 03.02.22 | ING Group Neutral | Goldman Sachs Group Inc. | |
| 03.02.22 | ABB (Asea Brown Boveri) Conviction Buy List | Goldman Sachs Group Inc. | |
| 03.02.22 | Deutsche Telekom Buy | Jefferies & Company Inc. | |
| 03.02.22 | UBS Overweight | JP Morgan Chase & Co. | |
| 02.02.22 | Vodafone Group Overweight | JP Morgan Chase & Co. | |
| 02.02.22 | Vodafone Group Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 02.02.22 | UBS Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 02.02.22 | Rio Tinto Sell | UBS AG | |
| 02.02.22 | Novartis Market-Perform | Bernstein Research | |
| 02.02.22 | Novartis Underweight | JP Morgan Chase & Co. | |
| 02.02.22 | Vodafone Group Outperform | Bernstein Research | |
| 02.02.22 | Diageo Buy | UBS AG | |
| 02.02.22 | Santander Sector Perform | RBC Capital Markets | |
| 02.02.22 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 02.02.22 | Vodafone Group Conviction Buy List | Goldman Sachs Group Inc. | |
| 02.02.22 | Novartis Underweight | Barclays Capital | |
| 02.02.22 | AXA Overweight | Barclays Capital | |
| 02.02.22 | Allianz Equal Weight | Barclays Capital | |
| 02.02.22 | UBS Equal Weight | Barclays Capital | |
| 02.02.22 | GSK Neutral | JP Morgan Chase & Co. | |
| 02.02.22 | Vodafone Group Buy | Jefferies & Company Inc. | |
| 02.02.22 | Vodafone Group Overweight | JP Morgan Chase & Co. | |
| 02.02.22 | Santander Neutral | JP Morgan Chase & Co. | |
| 02.02.22 | Santander Hold | Jefferies & Company Inc. | |
| 02.02.22 | GSK Buy | Jefferies & Company Inc. | |
| 02.02.22 | Novartis Buy | Jefferies & Company Inc. | |
| 02.02.22 | UBS Outperform | Credit Suisse Group | |
| 02.02.22 | UBS Outperform | RBC Capital Markets | |
| 02.02.22 | UBS Overweight | JP Morgan Chase & Co. | |
| 01.02.22 | Novartis Underweight | JP Morgan Chase & Co. | |
| 01.02.22 | Allianz Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 01.02.22 | UBS Outperform | RBC Capital Markets | |
| 01.02.22 | SAP Buy | Warburg Research |
